←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Inhibitors, NSCLC Clinical Trials
Antonio Chiappori
MD
🏢Moffitt Cancer Center🌐USA
Senior Member, Thoracic Oncology
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Antonio Chiappori leads NSCLC clinical trials evaluating KRAS inhibitors and combinations at Moffitt. He investigates sequencing of targeted therapy and immunotherapy in KRAS-mutant disease. His clinical work informs label expansion for pan-KRAS agents.
Share:
🧪Research Fields 研究领域
KRAS G12C
lung cancer trials
sotorasib
adagrasib
thoracic oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Antonio Chiappori 的研究动态
Follow Antonio Chiappori's research updates
留下邮箱，当我们发布与 Antonio Chiappori（Moffitt Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment